ACHIEVING OPTIMAL LIPID LEVELS IN PATIENTS WITH CORONARY ARTERY DISEASE IN CLINICAL PRACTICE  by Subramanya, Raghunandan Dudda et al.
A51.E484
JACC March 9, 2010
Volume 55, issue 10A
 HYPERTENSION, LIPIDS AND PREVENTION 
ACHIEVING OPTIMAL LIPID LEVELS IN PATIENTS WITH CORONARY ARTERY DISEASE IN CLINICAL 
PRACTICE
ACC Poster Contributions
Georgia World Congress Center, Hall B5
Sunday, March 14, 2010, 3:30 p.m.-4:30 p.m.
Session Title: The Effects of Statin Therapy on Coronary Disease
Abstract Category: Pharmacology/Hormones/Lipids—Clinical
Presentation Number: 1072-88
Authors: Raghunandan Dudda Subramanya, Scott E. Hessen, Longjan Liu, Mark F. Victor, Dean G. Karalis, Drexel University College of Medicine, 
Philadelphia, PA, Cardiology Consultants of Philadelphia, Philadelphia, PA
Background: Recent guidelines call for more aggressive lipid goals in patients (pts) with coronary artery disease (CAD). The purpose of this study 
was to evaluate whether pts with CAD achieve their recommended lipid goals in clinical practice.
Methods: We conducted a retrospective analysis of outpatient electronic health records from a large private cardiology practice group over a 12 
month period (9/08 to 9/09) . Their most recent lipid profile was used and all CAD patients who had a full lipid panel, including total cholesterol, 
low density lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL), and triglycerides (TG) were included.
Results: We identified 10,040 pts; 66.2% men; mean age 71 ±11 years. Rates of achieving individual lipid targets are shown below. Mean lipid 
levels in all pts were: LDL 81.7 mg/dL; non-HDL 109.3 mg/dL; TG 210.5 mg/dl; HDL 38.6 mg/dL. A combined goal of LDL<100 mg/dL plus non-
HDL<130 mg/dL and of LDL<70 mg/dL plus non-HDL<100 mg/dL was achieved in 75.3% and 31.4% of pts respectively. LDL<100 mg/dL and 
normal HDL and TG levels was achieved in 39.6% of pts, while only 17.1% achieved an LDL<70 mg/dL plus normal HDL and TG levels.
Conclusions: In current clinical practice while most CAD patients achieve their minimal recommended lipid targets, most do not achieve the lower 
recommended targets for LDL and non-HDL. There exists a significant opportunity to more aggressively treat CAD pts with lipid lowering therapy.
